跳至主要内容
临床试验/NCT01375088
NCT01375088已完成2 期

Phase I Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers

Mashhad University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
1
主要终点
NCI.CTC Scale

研究概览

简要总结

The purpose of this study is to determine whether propolis is effective in the treatment and prevention of radiotherapy induced oral mucositis.

详细描述

Patients with head and neck malignancy with inclusion criteria randomly divide in 2 groups and take the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • need of radiotherapy
  • at least half of the mouth in the field of radiation
  • dose 50 -70 Gy
  • head & neck malignancy

排除标准

  • systemic disease
  • FBS > 150 WBC > 3000
  • history of radiotherapy
  • need of chemotherapy
  • systemic disease

研究组 & 干预措施

placebo mouth wash

Placebo Comparator

10 patients swish & swallow 15 ml placebo mouth wash for at least 5 min from the first session of radiotherapy until the last session

干预措施: propolis (Drug)

propolis

Active Comparator

10 patients swish & swallow 15 ml propolis mouth wash for at least 5 min from the first session of radiotherapy until the last session

干预措施: propolis (Drug)

结局指标

主要结局

NCI.CTC Scale

时间窗: 9 month

we use NCI-CTC scale for patients in 2 groups to assess effect of propolis mouth wash on prevention and treatment of mucositis in patients under radiotherapy.We measured signs(size and sypmtoms) of mucositis by NCI-CTC scale and also we assessed the onset of the mucositis to describe the prevention efficacy of propolis.

次要结局

  • hyposalivation scale(9 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ATESSA PAKFETRAT

Associate professor

Mashhad University of Medical Sciences

研究点 (1)

Loading locations...

相似试验